Is Sharon Bio-Medicine Ltd debt-free?

Yes, Sharon Bio-Medicine Ltd is debt-free with a debt-to-equity ratio of -1.40.

Home

Sharon Bio-Medicine Ltd

Sharon Bio-Medicine Ltd Financials

Sharon Bio-Medicine Ltd Financial Statement

Sharon Bio-Medicine Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Mar 2023	Dec 2022	Sep 2022
Revenue	45.03	59.83	56.02
Operating Expense	40.72	47.45	44.47
Net Profit	1.81	9.47	8.85
Net Profit Margin	4.02	15.83	15.80
Earning Per Share	3.14	16.45	15.37
EBIDTA	4.31	12.39	11.56
Effective Tax Rate	TBA	TBA	TBA

Particulars	Mar 2023
Revenue	45.03
Operating Expense	40.72
Net Profit	1.81
Net Profit Margin	4.02
Earning Per Share	3.14
EBIDTA	4.31
Effective Tax Rate	TBA

Sharon Bio-Medicine Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2016	Jun 2015	Jun 2014
Total Revenue Annual	253.45	833.95	1,313.77
Operating Expenses Annual	387.29	868.34	1,156.71
Operating Profit Annual	-203.24	-108.39	158.74
Interest Annual	70.98	93.64	58.63
Depreciation	15.01	19.17	15.35
Net Profit Annual	-299.20	-225.86	69.62
Tax Annual	9.97	4.66	15.14

Particulars	Mar 2016
Total Revenue Annual	253.45
Operating Expenses Annual	387.29
Operating Profit Annual	-203.24
Interest Annual	70.98
Depreciation	15.01
Net Profit Annual	-299.20
Tax Annual	9.97

Sharon Bio-Medicine Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

No Data Availabe

Sharon Bio-Medicine Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

No Data Availabe

Sharon Bio-Medicine Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2016	Jun 2015	Jun 2014
Fixed Assets Annual	318.56	332.10	325.02
Total Current Assets Annual	395.09	668.86	812.35
Non Current Assets Annual	327.75	342.66	349.28
Total Shareholders Funds Annual	-181.49	118.08	343.94
Total Assets Annual	722.84	1,011.53	1,161.63

Particulars	Mar 2016
Fixed Assets Annual	318.56
Total Current Assets Annual	395.09
Non Current Assets Annual	327.75
Total Shareholders Funds Annual	-181.49
Total Assets Annual	722.84

Sharon Bio-Medicine Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Sharon Bio-Medicine Ltd Financials

As of Sep 12, 2025, Sharon Bio-Medicine Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Sharon Bio-Medicine Ltd is with a debt-to-equity ratio of -1.40.

In FY 2024 , Sharon Bio-Medicine Ltd recorded a total revenue of approximately 190.24 Cr marking a significant milestone in the company's financial performance.

Sharon Bio-Medicine Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.1% annually, respectively..

Sharon Bio-Medicine Ltd's current PE ratio is .

Sharon Bio-Medicine Ltd's ROCE averaged 7.7% from the FY ending March 2021 to 2023, with a median of 8.0%. It peaked at 8.1% in March 2022, reflecting strong capital efficiency over the period..

Sharon Bio-Medicine Ltd's latest EBIT is Rs. 19.07 Cr, surpassing the average EBIT of Rs. 17.02 Cr over the 5 years..